Ubs Group Ag Gh Research PLC Put Options Transaction History
Ubs Group Ag
- $397 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding GHRS
# of Institutions
36Shares Held
17MCall Options Held
25.5KPut Options Held
19.8K-
Bvf Inc San Francisco, CA10.4MShares$130 Million3.32% of portfolio
-
Rtw Investments, LP New York, NY3.33MShares$41.6 Million0.57% of portfolio
-
Verition Fund Management LLC Greenwich, CT1.13MShares$14.1 Million0.09% of portfolio
-
Cormorant Asset Management, LP Boston, MA593KShares$7.41 Million0.36% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA573KShares$7.15 Million2.15% of portfolio
About GH Research PLC
- Ticker GHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,020,800
- Market Cap $650M
- Description
- GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...